Moderna Announces FDA Authorization of Moderna COVID-19 Vaccine in U.S.

CAMBRIDGE, Mass.--(BUSINESS WIRE)--Dec. 18, 2020-- Moderna, Inc., (Nasdaq: MRNA) a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines today announced that the U.S. Food and Drug Administration’s...
Source: Drugs.com - Clinical Trials - Category: Pharmaceuticals Source Type: clinical trials